Myeloid differentiation continues to reveal the complexity of nuclear receptor signaling.
Campbell
Moray J
MJ
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, USA. Moray.Campbell@RoswellPark.org
D002454:Cell Differentiation; D002460:Cell Line; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism / Q000494:pharmacology; D018922:HL-60 Cells; D006801:Humans; D035683:MicroRNAs / Q000378:metabolism; D022423:Myeloid Cells / Q000166:cytology*; D018167:Receptors, Calcitriol / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D018168:Receptors, Retinoic Acid / Q000378:metabolism; D015398:Signal Transduction
D050759:Cyclin-Dependent Kinase Inhibitor p21; D035683:MicroRNAs; D018167:Receptors, Calcitriol; D018160:Receptors, Cytoplasmic and Nuclear; D018168:Receptors, Retinoic Acid